Stay updated on AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial
Sign up to get notified when there's something new on the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page.

Latest updates to the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check8 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.9%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page.